Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Iannacone

Showing results (31-40 of 139) with videos related to

Pageof 14
Sort By:
Immunology Letters|March 29, 2022
Heterogeneity of tissue resident memory T cellsŠpela Konjar, Xenia Ficht, Matteo Iannacone, et al.
Journal of Hepatology|August 25, 2007
Acute thrombocytopenia after liver transplant: role of platelet activation, thrombopoietin deficiency and response to high dose intravenous IgG treatmentAngelo Nascimbene, Matteo Iannacone, Bruno Brando, et al.
Nature Reviews. Immunology|April 2, 2026
Abortive infection: T cells as early, antibody-independent defendersLeo Swadling, Valeria Fumagalli, Mala K Maini, et al.
Annual Review of Immunology|February 15, 2024
Priming and Maintenance of Adaptive Immunity in the LiverKeigo Kawashima, Francesco Andreata, Cristian Gabriel Beccaria, et al.
Journal of Hepatology|February 24, 2007
HBV pathogenesis in animal models: recent advances on the role of plateletsMatteo Iannacone, Giovanni Sitia, Zaverio M Ruggeri, et al.
Virulence|November 30, 2020
Role of LFA-1 integrin in the control of a lymphocytic choriomeningitis virus (LCMV) infectionMario Perro, Matteo Iannacone, Ulrich H von Andrian, et al.
European Journal of Immunology|December 19, 2025
Optimising Recovery of Hepatic Regulatory T Cells: A Practical Guide Using ARTC2 BlockadeCaitlin Abbott, Violette Mouro, Chiara Perucchini, et al.
Journal of Hepatology|July 30, 2024
Intrahepatic immunity to hepatitis B virusValentina Venzin, Cristian G Beccaria, Francesco Andreata, et al.
Immunological Reviews|September 25, 2025
Tertiary Lymphoid Structures Across Organs: Context, Composition, and Clinical LeversStephane M Guillaume, Cristian G Beccaria, Matteo Iannacone, et al.
Journal of Leukocyte Biology|August 29, 2006
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic miceGiovanni Sitia, Matteo Iannacone, Susanne Müller, et al.
Pageof 14

Showing results (31-40 of 139) with videos related to

Sort By:
Pageof 14
Immunology Letters|March 29, 2022
Heterogeneity of tissue resident memory T cellsŠpela Konjar, Xenia Ficht, Matteo Iannacone, et al.
Journal of Hepatology|August 25, 2007
Acute thrombocytopenia after liver transplant: role of platelet activation, thrombopoietin deficiency and response to high dose intravenous IgG treatmentAngelo Nascimbene, Matteo Iannacone, Bruno Brando, et al.
Nature Reviews. Immunology|April 2, 2026
Abortive infection: T cells as early, antibody-independent defendersLeo Swadling, Valeria Fumagalli, Mala K Maini, et al.
Annual Review of Immunology|February 15, 2024
Priming and Maintenance of Adaptive Immunity in the LiverKeigo Kawashima, Francesco Andreata, Cristian Gabriel Beccaria, et al.
Journal of Hepatology|February 24, 2007
HBV pathogenesis in animal models: recent advances on the role of plateletsMatteo Iannacone, Giovanni Sitia, Zaverio M Ruggeri, et al.
Virulence|November 30, 2020
Role of LFA-1 integrin in the control of a lymphocytic choriomeningitis virus (LCMV) infectionMario Perro, Matteo Iannacone, Ulrich H von Andrian, et al.
European Journal of Immunology|December 19, 2025
Optimising Recovery of Hepatic Regulatory T Cells: A Practical Guide Using ARTC2 BlockadeCaitlin Abbott, Violette Mouro, Chiara Perucchini, et al.
Journal of Hepatology|July 30, 2024
Intrahepatic immunity to hepatitis B virusValentina Venzin, Cristian G Beccaria, Francesco Andreata, et al.
Immunological Reviews|September 25, 2025
Tertiary Lymphoid Structures Across Organs: Context, Composition, and Clinical LeversStephane M Guillaume, Cristian G Beccaria, Matteo Iannacone, et al.
Journal of Leukocyte Biology|August 29, 2006
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic miceGiovanni Sitia, Matteo Iannacone, Susanne Müller, et al.
Pageof 14